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Phorbol esters (phorbol 12-myristate 13-acetate; PMA) and a-interferon (a-IFN) act through divergent signal transduction pathways to induce 
B chronic lymphocytic leukaemia cells (B-CLL) to undergo plasmacytoid ifferentiation in vitro. By using a panel of PMA-inducible early response 
gene probes we show that these two different effecters are coupled to second messenger pathways that do not converge on a common gene regulatory 
programme in differentiation of B-CLL cells. Moreover, using the calcium ionophore, A23187, four distinct regulatory classes of early response 
gene could be defined implying that multiple regulatory pathways may mediate the process of terminal differentiation in B lymphocytes. 
Early response gene regulation; Phorbol ester; B lymphocyte differentiation 
1. INTRODUCTION 
B-cell chronic lymphocytic leukaemia cells (B-CLL) 
represent a monoclonal expansion of malignant B lym- 
phocytes arrested at a stage of differentiation in- 
termediate between the pre-B cell and the resting 
mature peripheral blood B lymphocyte [1,2]. This dif- 
ferentiation arrest can be overcome by treatment of the 
cells with a variety of agents such as phorbol ester 
(phorbol IZmyristate 13:acetatei PMAj and various 
lymphokines particularly a-interferon (cu-IFN) [3-e]. 
In vitro induced plasmacytojd ifferentiation of B&LL 
cells provides a useful RIP&~ SYS~WI in which to study 
mechanisms that co-ordinately regulate gene expression 
during terminal differentiation of B lymphocytes in 
response to extracellular signals. Recent studies have 
shown that PMA-induced plasmacytoid differentiation 
of B-CLL cells is preceded by the initiation of a com- 
plex gene regulatory programme characterised by a 
rapid transient stimulation in expression of a large 
number (probably >lO’) of early response genes 
(ERGS) [7], which include in addition to members of 
the nuclear proto-oncogene families many anonymous 
genes of unknown function [7,8]. The effects of PMA 
on many cell types, including lymphocytes are thought 
to be largely mediated by substitution for diacylglycerol 
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in the direct activation of the protein kinase C (PKC) 
signal transduction pathway [9]. In contrast, the second 
messenger pathways activated by wIFN remain largely 
unknown but do not appear to involve PKC nor the 
other classical second messenger pathways coupled to 
intracellular calcium or cyclic adenosine 
monophosphate [lo]. 
In this report we have used a panel of ERG probes 
to investigate the relationship between the gene 
regulatory pathways activated by PMA and those ac- 
tivated by a-IFN in B-CLL cells. Our results show that 
only a minor subset of PMA-responsive ERGS are in- 
dueed by cu-IFN indicating that the divergent sigpal 
transduction pathways coupled to these two different 
effecters do not converge on a common gene regulatory 
programme in terminal B lymphocyte differentiation. 
In addition, using the calcium ionophore, A23187, we 
show that 4 regulatory classes of ERG can be defined 
on the basis of expression characteristics implying that 
multiple gene regulatory pathways may mediate the 
process of induced terminal differentiation in B lym- 
phocytes. 
2. MATERIALS AND METHODS 
2.1. Materials 
Phorbol 12-myristate 13-acetate and A23187 were purchased from 
Sigma (Poole, Dorset, UK). cu-IFN was obtained from Kirby Warrick 
Pharmaceuticals (Suffolk, UK) and [(r-32P]dCTP was obtained from 
Amersham International (Bucks, UK). Cell culture materials were 
obtained from Gibco (Grand Island, NY, USA). 
2.2. Cell isolation and culture 
Mononuclear cell preparations were obtained from B-CLL patients 
with peripheral ymphocyte counts >60 x 10’11 by a single step gra- 
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dient centrifugation on Ficoll-Hypaque and depleted of monocytes 
by adherence to plastic. Freshly prepared B-CLL populations con- 
tained < 1% monocytes and <5% T lymphocytes as judged by flow 
cytometry and immunofluorescence with T cell-specific monoclonal 
antibody (CD3) (data not shown). After overnight incubation in 
serum-free RPMI-1640 medium B-CLL cells were incubated (lo6 
cells/ml) in RPMI-1640 medium supplemented with 10% foetal calf 
serum, 2 mM glutamine and 20~g/ml gentamicin with or without 
previously determined optimal concentrations of PMA (30 nM), 
A23 187 (250 nM) alone or in combination with PMA (30 nM), or cy- 
IFN (500 units/ml). Cells were maintained at 37°C in a humidified 
incubator. 
2.3. RNA hybridisation analysis 
At various times B-CLL cells (108) were harvested and total RNA 
was extracted by the guanidium isothiocyanate procedure [ 111. 2 pg 
samples per time point were electrophoresed through 1% agarose gels 
in 0.8 M formaldehyde [12]. RNA was blotted on nylon filters and 
hybridised to ‘*P-labelled probes (lo6 cpm/ml) for 24 h. Filters were 
then washed with 2 x SSC, 4 times (30 s), with 2 x SSC 4 times 
(20 min), 1% SDS, in 2 x SSC at 60°C for 20 min and finally at 60°C 
in 0.1 x SSC (20 min). Autoradiography was performed at -70°C 
using DuPont, ‘Lightening Plus’ intensifying screens for 1-14 days. 
The c-myc probe was a 1.5 kb EcoRI-Hind111 genomic fragment 
containing the second myc exon [13]. The c-fos probe [14] was a 
1.5 kb EcoRI cDNA fragment (J.J. Murphy and J.D. Norton, un- 
published). A panel of 12 PMA-induced B-CLL ERGS previously 
cloned and characterised were also used in these experiments [7]. 
3. RESULTS 
The expression characteristics of 14 ERGS were 
studied after stimulation of B-CLL cells with either 
PMA, (Y-IFN or the calcium ionophore, A23187. Ex- 
pression was also analysed following stimulation of 
cells with PMA and A23 187 together, since these agents 
have previously been shown to act synergistically on 
many cell types including B-CLL cells [15]. The ERG 
panel comprised the proto-oncogenes c-fos and c-myc, 
together with a further 12 ‘anonymous’ ERG probes 
described previously [7]. 
Expression of c-myc was stimulated by PMA alone 
but no detectable increase in expression was observed _ _~. 
after induction of cells with either cu-IFN or A23 187 
(Table I, Fig. 1). A further 7 ERGS showed similar ex- 
pression characteristics to c-myc (illustrated for ERG 
19A in Fig. 1) with upregulation only in response to 
PMA but not with &FN or A23 187. 
c-myc and c-fos were not coordinately regulated. In 
contrast to c-myc, c-fos and another ERG, 3L11, were 
induced by both PMA and A23187 and to a lesser ex- 
tent by a-IFN (Table I, Fig. 1). Thus all 3 activating 
agents induced the ERGS c-fos and 3Lll to varying 
amounts. ERGS 1 R20 and 1 R 19 were induced in B-CLL 
cells following stimulation by both PMA and a-IFN 
but not by the calcium ionophore (Table I, Fig. 1). In 
contrast, ERGS lL3 and 4Bl were induced by PMA 
and A23187 but not by wIFN (Table I, Fig. 1). In- 
terestingly, ERG lL3 was the only gene which showed 
increased expression following stimulation with PMA 
and A23187 together compared to stimulation with 
PMA alone (Table I, Fig. 1). 
Table I 
Induction of early response genes by different agents relative to the 
PMA-induced response 
Gene A23187 PMA + A23187 c~-IFN 
c-myc 
c-fos 
lL3 
lL4 
lR19 
1 R20 
lR21 
3L2 
3L3 
3Lll 
4Bl 
5L3 
1OA 
19A 
- +++ - 
++ +++ + 
++ ++++ _ 
+++ - 
- +++ ++ 
+++ - 
+++ ++ 
- +++ - 
- +++ _ 
++ +++ if 
++ +++ - 
- +++ _ 
- +++ _ 
+++ - 
+ + + = level of induction of early response genes by PMA alone 
ERGS induced by either PMA or calcium ionophore 
showed similar kinetics of expression (Fig. 1). 
However, cu-IFN-stimulated expression of ERGS lR19 
and 3Lll was delayed compared to PMA-induced ex- 
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-- 
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Fig. I. Northern blot time course of ERG expression in B-CLL cells 
after stimulation with different agents. B-CLL cells were stimulated 
for the times indicated with (A) PMA (30 nM), (B) PMA (30 nM) 
and A23187 (250 nM) together, (C) A23187 (250 nM) alone or (D) U- 
IFN (500 units/ml). Total RNA was isolated and Northern blots were 
hybridised with gene probes. The position of the 28 S and 18 S 
ribosomal RNA bands are shown. 
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pression, and cy-IFN-stimulated expression of ERG 
lR20 was more rapid and transient than with PMA 
(Fig. 1). 
4. DISCUSSION 
Using B-CLL cells as a model, the relationship bet- 
ween the early gene regulatory programme elicited by 
three different activating agents; PMA, a-IFN and the 
calcium ionophore, A23187, was studied during in vitro 
induced plasmacytoid differentiation of B lym- 
phocytes. Although the 12 ‘anonymous’ ERGS used in 
the present study were previously cloned on the basis of 
their inducibility in response to PMA in B-CLL cells 
[7], a sizable proportion of them were found to be in- 
duced in response to a-IFN and/or A23187. 
Calcium ionophores have been reported to act 
synergistically with PMA on a number of cell types in- 
cluding B lymphocytes to enhance the differentiative 
response [ 151. However, Klemtz et al. previously 
reported no synergistic effect of A23187 on PMA- 
induced expression of the nuclear proto-oncogenes c- 
fos and c-myc in mouse B lymphocytes [161. Consistent 
with this we found that, with the exception of the ERG 
lL3, A23187 did not have any synergistic effect on 
PMA-induced expression of ERGS in B-CLL cells. This 
suggests that the potentiating effects of ionophores on 
PMA-induced plasmacytoid differentiation is mediated 
through a relatively limited number of ERGS. 
Studies on normal B lymphocytes have also shown 
that calcium ionophore alone stimulates expression of 
both c-fos and c-myc [16]. In contrast, we found that 
in B-CLL cells only c-fos was induced in response to 
treatment with ionophore alone. These differences may 
well reflect changes in calcium-dependent signalling 
pathways associated with malignant B lymphocytes. 
In contrast to calcium ionophore which by itself does 
not affect significant phenotypic changes in B-CLL 
cells [ 151, a-IFN induces a plasmacytoid differentiative 
response similar to that elicited by PMA [5,6]. 
However, the observation that only 4 of the 14 ERGS 
were induced by a-IFN rather implies that these two 
different effecters activate signal transduction 
pathways which do not converge on a common gene 
regulatory programme in terminal B lymphocyte dif- 
ferentiation. Interestingly, we recently found that 
PMA-induced expression of the a-IFN-responsive 
genes c-fos, lR19 and 3Lll and the A23187-responsive 
genes 4B 1 and 1 L3 is mediated through a protein kinase 
C-independent mechanism (J.J. Murphy and J.D. Nor- 
ton, submitted for publication). This raises the 
possibility that these ERGS are coupled to signal 
transduction pathways activated by both PMA and (Y- 
IFN/A23187. Alternatively, expression of these ERGS 
may be coupled through divergent signal transduction 
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pathways to distinct PMA/a-IFN/A23187-responsive 
&regulating determinants hared by each gene. Such 
an explanation may well account for the expression 
characteristics of the c-fos gene which contains, in ad- 
dition to the classical serum response element [ 171 and 
‘APl’-like site [18] involved in PMA-responsiveness, a 
short region within the promoter domain displaying 
homology to interferon response elements (see [19]). 
Whilst the precise regulatory determinants of dif- 
ferent ERGS in B cells remain to be determined, our 
data reveal 4 distinct regulatory classes that can be 
defined on the basis of induced expression 
characteristics: (i) genes induced by PMA alone, (ii) 
genes induced by PMA and (r-IFN, (iii) genes induced 
by PMA and calcium ionophore, (iv) genes induced by 
all three effecters. These observations imply that multi- 
ple gene regulatory mechanisms act on B lymphocytes 
during the process of induced terminal differentiation. 
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